SCHEMBL20374725

SCHEMBL20374725

C=CC(=O)N[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C([C@H](C)CC[C@@H](C)C(C)C)CC[C@@H]32)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 2/20 0.56
▸ ACHE P22303 1/20 0.55
▸ EPHA2 P29317 6/20 0.53
▸ GPBAR1 Q8TDU6 5/20 0.53
▸ CASP7 P55210 3/20 0.53
▸ HIF1A Q16665 3/20 0.53
▸ VDR P11473 3/20 0.53
▸ TP53 P04637 2/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ BLM P54132 2/20 0.53
▸ TDP1 Q9NUW8 2/20 0.53
▸ USP2 O75604 2/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ MDM4 O15151 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ HSPD1 P10809 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ PTPN2 P17706 1/20 0.53
▸ PTPN1 P18031 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20370398 1.00 BCHE (0.56) BCHEACHEEPHA2GPBAR1CASP7
SCHEMBL20374726 0.90 BCHE (0.54) BCHEACHEEPHA2GPBAR1CASP7
SCHEMBL20370399 0.90 BCHE (0.54) BCHEACHEEPHA2GPBAR1CASP7
SCHEMBL23635434 0.90 CYP2D6 (0.62) BCHEACHEEPHA2GPBAR1CASP7
SCHEMBL20370396 0.90 CYP2D6 (0.62) BCHEACHEEPHA2GPBAR1CASP7
SCHEMBL20374544 0.90 CYP2D6 (0.62) BCHEACHEEPHA2GPBAR1CASP7
SCHEMBL23635432 0.90 CYP2D6 (0.62) BCHEACHEEPHA2GPBAR1CASP7
SCHEMBL20374506 0.90 CYP2D6 (0.62) BCHEACHEEPHA2GPBAR1CASP7
SCHEMBL20370389 0.90 CYP2D6 (0.62) BCHEACHEEPHA2GPBAR1CASP7
SCHEMBL19853973 0.81 BCHE (0.51) BCHEACHEEPHA2GPBAR1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, MBD2, PAXBP1 BCHE 4349/4885ACHE 3570/4885EPHA2 1249/4885
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device SP1, MBD2, PAXBP1 BCHE 4349/4885ACHE 3570/4885EPHA2 1249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback